Covid 19 Research using Clinical Trials (Home Page)
SARS-Cov2 testingWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug1391 | self-administered questionnaire Wiki | 0.71 |
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D007239 | Infection NIH | 0.07 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The aim of the study is to determine the incidence o of SARS-cov2 infection among health care
workers highly exposed to covid 19 during 10 weeks et to analyze the determinants of their
occupational and environmental exposure. Every 14 days, we performed SARS-Cov2 RT- PCR,
serological testing and clinical questionnaire among a cohort of 100 HCW with a high degree
of exposure to covid19 infection. Information about occupational exposure as the workplace,
the activity of care, the characteristics of patient infected are captured, as well as
environmental or personal exposure.
The results will support the design of a new care organization and will define new ways of
protection for patients (covid or not covid 19) and prevention for HCW.
NCT04362267 Sars-CoV2 Other: self-administered questionnaire Diagnostic Test: SARS-Cov2 testing
Primary Outcomes
Measure: the incidence of SARS- Cov2 infection Heath Care Worker diagnosed by the positivity of SARS-Cov2 RT-PCT and serological testing Time: at 14 weeks
Secondary Outcomes
Measure: the incidence of SARS- Cov2 infection Heath Care Worker diagnosed by the positivity of SARS-Cov2 RT-PCT and serological testing Time: once every 14 days for an average of 14 weeks
Measure: Occupational exposures associated with the SARS-Cov2 infection Time: once every 14 days for an average of 14 weeks
Measure: Environmental exposures associated with the SARS-Cov2 infection Time: once every 14 days for an average of 14 weeks
No related HPO nodes (Using clinical trials)